Alkermes Plc (ALKS)
Healthcare
Drug Manufacturers - Specialty & Generic
49.50 $
+1.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Alkermes Plc (ALKS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 145 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100 | 107 | 21 | 146 | 82 | 190 | 99 | 150 | 102 | 170 | -166 | 145 | 251 | |
| 19 | 18 | 8.1 | 6.7 | 7.0 | 6.8 | 7.4 | 7.8 | 8.1 | 3.8 | 19 | 30 | 62 | |
| 24 | 26 | 33 | 21 | 23 | 21 | 23 | 25 | 25 | -72 | 36 | 31 | 20 | |
| 15 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 18 | -2.3 | -66 | 15 | -54 | 6.9 | 43 | 31 | -46 | 91 | -160 | 12 | -103 | |
| 14 | 17 | 8.3 | 7.1 | 8.3 | 9.8 | 10 | 13 | 17 | 0.0 | 4.1 | 8.1 | 30 | |
| -119 | -21 | -40 | 52 | -109 | -14 | 9.1 | -29 | -6.7 | 322 | -2,077 | -2.4 | -1,764 | |
| 2.3 | 33 | – | – | – | – | – | – | – | – | – | – | – | |
| -0.8 | -2.4 | -28 | -85 | -116 | 0.0 | -29 | -1.7 | 29 | -31 | -28 | – | – | |
| -0.8 | – | – | – | -0.8 | -290 | 0.0 | 0.0 | 0.0 | 0.0 | 1,512 | – | – | |
| 1.6 | -276 | -18 | -83 | -111 | -282 | 0.7 | 0.4 | 0.3 | 11 | 1,475 | 17 | 1,503 | |
| -18 | -190 | -37 | 114 | -139 | -105 | 109 | 121 | 95 | 503 | -768 | 160 | -9.7 | |
| 85 | 90 | 13 | 139 | 73 | 181 | 89 | 137 | 84 | 170 | -170 | 137 | 222 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.